Innovate UK Biomedical Catalyst Accelerator Provider Pool

MODERATE Tx Startup

Strategy Notes

Strong sector and stage alignment—computational drug discovery fits BMC's therapeutic/diagnostic remit and pre-seed positioning. However, applicant is France-based (Île-de-France primary), reducing fit; UK is secondary geography. Incomplete page content prevents assessment of funding range, eligibility geography, and deadline.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: accelerator
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · This competition is a provider pool Expression of Interest for organisations that design and deliver accelerator programmes to SMEs — not for startups seeking acceleration. Eniola is a startup founder, not an accelerator operator. Additionally, the competition closed 4 March 2026 (today is 9 July 2026), applicant is not UK-registered, and there is explicitly no funding attached to this EoI.